Astellas Pharma Inc logo

Astellas Pharma Inc - ADR

OTCPK:ALPMY (Japan)   ADR
$ 9.48 -0.2 (-2.07%) 10:08 PM EST
At Loss
P/B:
1.78
Market Cap:
$ 17.00B
Enterprise V:
$ 20.76B
Volume:
145.78K
Avg Vol (2M):
354.77K
Also Trade In:
Volume:
145.78K
At Loss
Avg Vol (2M):
354.77K

Business Description

Description
Astellas Pharma Inc is a specialty global pharmaceutical company. The company focuses on accelerating the discovery, development and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-treat diseases. The group is committed to driving innovation in immuno-oncology, gene therapy, mitochondria, blindness and regeneration, and targeted protein degradation. The company operates its business in approximately 70 countries around the world. Its core products include anticancer agents like XTANDI, XOSPATA, and PADCEV; VEOZAH for the treatment of vasomotor symptoms due to menopause; Betanis / Myrbetriq / BETMIGA for the treatment of overactive bladder (OAB); and Prograf, an immunosuppressant for organ transplantation.

Financials

ALPMY's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ALPMY

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Astellas Pharma Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 10,885.972
EPS (TTM) ($) -0.008
Beta 0.27
Volatility % 16.03
14-Day RSI 36.29
14-Day ATR ($) 0.245644
20-Day SMA ($) 9.72245
12-1 Month Momentum % -42.42
52-Week Range ($) 9.15 - 16.91
Shares Outstanding (Mil) 1,793.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Astellas Pharma Inc Filings

Filing Date Document Date Form
No Filing Data

Astellas Pharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Astellas Pharma Inc Frequently Asked Questions

What is Astellas Pharma Inc(ALPMY)'s stock price today?
The current price of ALPMY is $9.48. The 52 week high of ALPMY is $16.91 and 52 week low is $9.15.
When is next earnings date of Astellas Pharma Inc(ALPMY)?
The next earnings date of Astellas Pharma Inc(ALPMY) is .
Does Astellas Pharma Inc(ALPMY) pay dividends? If so, how much?
The  Dividend Yield %  of Astellas Pharma Inc(ALPMY) is 2.47% (As of Today), Highest Dividend Payout Ratio of Astellas Pharma Inc(ALPMY) was 1.11. The lowest was 0.33. And the median was 0.47. The  Forward Dividend Yield % of Astellas Pharma Inc(ALPMY) is 4.76%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1